Share Price | Accretion Nutraveda Ltd Stock Analysis & Recommendation

Q: Why is Accretion Nutraveda Ltd falling/rising?

As of 16-Mar, Accretion Nutraveda Ltd's stock price is rising, currently at Rs 197.00, which reflects an increase of Rs 11.0 or 5.91%. This rise is supported by several factors. Over the past week, the stock has outperformed the benchmark Sensex, gaining 5.91% while the Sensex has declined by 2.66%. In the last month, the stock has shown a significant increase of 11.77%, contrasting with the Sensex's drop of 9.34%. Today's trading performance indicates a strong start, with the stock opening with a gain of 2.15% and reaching an intraday high of Rs 197, marking a 5.91% increase. Additionally, Accretion Nutraveda Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price movement. However, it is important to note that there has been erratic trading, with the stock not trading on 3 out of the last 20 days, and a decline in delivery volume by 41.18% against the 5-day average, indicating a potential concern regarding investor participation. Despite these factors, the overall performance today shows that the stock is currently on an upward trajectory.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

4.0 k (-37.50%) Volume

Shareholding (Feb 2026)

FII

6.04%

Held by 1 FIIs

DII

6.51%

Held by 0 DIIs

Promoter

73.48%

Why is Accretion Nutraveda Ltd falling/rising?

17-Mar-2026

As of 16-Mar, Accretion Nutraveda Ltd's stock price is at Rs 197.00, reflecting a 5.91% increase. The stock has outperformed the Sensex recently, showing strong trading performance, although there are concerns about erratic trading and declining delivery volume.

View full answer

Which are the latest news on Accretion Nutrav?

24-Mar-2026

No latest news for Accretion Nutrav found.

Compare Accretion Nutrav with Similar Stocks

Coral Labs.Brooks Lab.Natural Capsules

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 141 Cr (Micro Cap)

P/E

50.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.00

Return on Equity

0.00%

Price to Book

0.00

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Clarification On Price Movement

20-Feb-2026 | Source : BSE

Please find enclosed herewith clarification letter on Price Movement

Clarification sought from Accretion Nutraveda Ltd

19-Feb-2026 | Source : BSE

The Exchange has sought clarification from Accretion Nutraveda Ltd on February 19 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

The reply is awaited.

Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011

17-Feb-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Unicorn Fund

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.23

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

17.92%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

12.54%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

EV to EBIT

37.45

EV to EBITDA

35.03

EV to Capital Employed

EV to Sales

8.14

PEG Ratio

Dividend Yield

ROCE (Latest)

ROE (Latest)

Technicals key factors

Indicator

Weekly

Monthly

MACD

RSI

Bollinger Bands

KST

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Feb 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (6.04%)

Promoter with highest holding

Ankurkumar Shantilal Patel (14.7%)

Highest Public shareholder

Unicorn Fund (6.51%)

Individual Investors Holdings

10.48%

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Accretion Nutrav"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Accretion Nutrav"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Accretion Nutrav"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Accretion Nutrav"
  }
]

Company CV

About Accretion Nutraveda Ltd

Accretion Nutraveda Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f. May 2, 2025.

Company Coordinates

No Company Details Available